Glyphic Biotechnologies logo

Glyphic Biotechnologies

Next Generation Protein Sequencing.

34 employees · est. 2021 · Berkeley, United States

VS
ProFound Therapeutics logo

ProFound Therapeutics

Pioneering the expanded human proteome to reveal a universe of new medicines.

51 employees · est. 2022

Glyphic Biotechnologies is the older company (2021 vs 2022); ProFound Therapeutics is the larger of the two.

Side-by-Side Comparison

Glyphic Biotechnologies ProFound Therapeutics
Founded
2021 older 2022
Headquarters
Berkeley, United States Not tracked yet
Employees
34 51 larger
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Pharmaceutical
Funding Stage
Seed Unknown
Total Funding
Not tracked yet $75.00M
Funding Rounds
8 1
Services
Not tracked yet Expanded Human Proteome Analysis, Novel Protein Identification, Therapeutic Development Platforms
Target Customers
Not tracked yet Biopharmaceutical Companies, Research Institutions, Healthcare Providers, Biotech Researchers
Taxonomy
Proteomics, Protein Sequencing, NGPS, Life Sciences Expanded Human Proteome, Protein Detection Technologies, Therapeutic Potential, Novel Proteins, Connectivity And Functionality Of Proteins, Health And Disease Roles, Therapeutics Discovery, ProFoundry Platform, Biotechnology Innovation, Flagship Labs, Flagship Pioneering, Protein Research, Disease Biology, Medicinal Biochemistry
Website
glyphic.bio profoundtx.com
Glyphic Biotechnologies logo

About Glyphic Biotechnologies

Glyphic Biotechnologies is a biotechnology startup based in the United States, founded in 2021, with the slogan "Next Generation Protein Sequencing." The company is focused on revolutionizing the field of proteomics by sequencing proteins to gain novel insights into biology and disease. Unlike DNA,...

ProFound Therapeutics logo

About ProFound Therapeutics

ProFound Therapeutics is at the forefront of biotechnological innovation, driven by its mission to redefine the human proteome and develop a suite of novel medicines. Using its groundbreaking ProFoundry Platform, the company identifies and analyzes a vast array of proteins, shedding light on untappe...

We will tell you when either one moves

BounceWatch watches Glyphic Biotechnologies and ProFound Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Glyphic Biotechnologie... and ProFound Therapeutics — by email.

Frequently Asked Questions

Glyphic Biotechnologies — Next Generation Protein Sequencing.. ProFound Therapeutics — Pioneering the expanded human proteome to reveal a universe of new medicines.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Glyphic Biotechnologies has raised undisclosed funding while ProFound Therapeutics has raised $75.00M.
Glyphic Biotechnologies and ProFound Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Glyphic Biotechnologies with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Glyphic Biotechnologies on 9 Jun 2026, and ProFound Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes